Reported Reactions

Devices › Implant, dermal, for aesthetic use

Device brand name · Implant dermal for aesthetic use

Juvederm Ultra Plus Xc Tsk Us: medical device reports filed with FDA

495 reports name it, 2010–2026. Manufacturer given most often on reports: Allergan Pringy. Product code LMH.

495
device reports naming the brand
0% of all MAUDE reports · about 30 a year
5
reports, 12 months to August 2026
16 in the 12 months before
29.5%
classified as malfunction
7.2% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 495 reports that name the brand "Juvederm Ultra Plus Xc Tsk Us" (implant dermal for aesthetic use), received between March 2010 and June 2026; the manufacturer given most often on reports is Allergan Pringy. Spellings of one product vary from report to report.

5 reports arrived in the 12 months to August 2026, down 69% from 16 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (70.3%) and malfunction (29.5%); across all implant, dermal, for aesthetic use reports (product code LMH) death is recorded in 0.1% and malfunction in 7.2%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are detachment of device or device component (9.5%), detachment of device component (7.7%) and leak/splash (7.1%). The patient problems coded most often are edema, skin irritation and erythema. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

024Sep 2021: 2Oct 2021: 1Nov 2021: 1Dec 2021: 22022Jan 2022: 0Feb 2022: 1Mar 2022: 1Apr 2022: 1May 2022: 0Jun 2022: 1Jul 2022: 0Aug 2022: 2Sep 2022: 1Oct 2022: 0Nov 2022: 1Dec 2022: 12023Jan 2023: 0Feb 2023: 1Mar 2023: 2Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 4Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 1Dec 2023: 02024Jan 2024: 1Feb 2024: 0Mar 2024: 2Apr 2024: 3May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 1Oct 2024: 1Nov 2024: 3Dec 2024: 02025Jan 2025: 0Feb 2025: 3Mar 2025: 3Apr 2025: 1May 2025: 0Jun 2025: 3Jul 2025: 1Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 1Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 2May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0541072010: 720102011: 72012: 2120122013: 382014: 4420142015: 402016: 3220162017: 1072018: 8720182019: 382020: 1720202021: 132022: 920222023: 82024: 1120242025: 122026: 42026

Event type and report source

Event type, as classified on the report

Death0%0
Injury70.3%348
Malfunction29.5%146
Other0%0
Not given0.2%1

Who filed the report

Manufacturer report100%495
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 22,802 reports carrying product code LMH. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Detachment of device or device componentpart of the device came off479.5%1.9%
Detachment of device component387.7%1.7%
Leak/splashthe device leaked357.1%1%
Gel leak316.3%1.3%
Crackthe device cracked295.9%0.9%
Breakthe device broke234.6%0.9%
Improper or incorrect procedure or method153%7.5%
Expulsion122.4%1%
Migration or expulsion of device71.4%0.7%
Off-label use61.2%4.2%
Defective component51%0.1%
Difficult or delayed positioning51%0.2%
Clumping in device or device ingredient40.8%0%
Burst container or vessel30.6%0.3%
Difficult or delayed activation30.6%0.2%
Insufficient device problem information30.6%10.2%
Occlusion within devicethe device blocked30.6%0%
Migrationthe device moved from where it was placed20.4%0.4%
Coagulation in device or device ingredient10.2%0.1%
Delivery system failure10.2%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Edemaswelling from fluid12224.6%
Skin irritationirritated skin8116.4%
Erythemaskin redness5811.7%
Inflammationinflammation5711.5%
Painpain, site not specified5010.1%
Hypersensitivity/allergic reaction397.9%
Skin discoloration346.9%
Ecchymosis306.1%
Vascular system (circulation), impaired234.6%
Skin inflammation214.2%
Ischemia183.6%
Necrosisdeath of tissue183.6%
Itching sensation122.4%
Rashskin rash102%
Dyspneashortness of breath91.8%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureJuvederm Ultra Plus Xc Tsk UsProduct code LMHAll MAUDE reports
Reports49522,80226,136,888
Share of that pool—2.2%0%
Classified as death, per 1,000 reports019
Classified as injury70.3%83.7%36.2%
Classified as malfunction29.5%7.2%62.3%
Filed by the manufacturer100%95.3%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code LMH

BrandReportsLatest 12 monthsClassified as death
Sculptra1,593910%
Juvederm Voluma Xc/Lido Volume Unknown1,0471940.1%
Juvederm Voluma XC 27G 2 x 1mL901780%
Juvederm Ultra Xc Tsk Us68110%
Unk Volbella663700%
VOLBELLA with LIDOCAINE64150.2%
Juvederm VOLUMA WITH LIDOCAINE 1mL622230%
Radiesse Dermal Filler59600%
Juvederm Volume/Concentration/Additive Unknown502240.6%
Zyplast Collagen Implant46600%
VOLIFT with LIDOCAINE458100%
Unk Juvederm Volux4451330%
Radiesse Injectable Implant44100%
JUVEDERM VOLLURE XC 2x1 mL427240.5%
Juvederm Voluma Volume/Additive Unknown426130%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Juvederm Ultra Plus Xc Tsk Us reports

How many FDA reports name Juvederm Ultra Plus Xc Tsk Us?

495 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 5 in the latest 12 months.

What kinds of events are reported?

injury (70.3%) and malfunction (29.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

detachment of device or device component (9.5%), detachment of device component (7.7%), leak/splash (7.1%), gel leak (6.3%) and crack (5.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Juvederm Ultra Plus Xc Tsk Us was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.